A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids.
作者信息
Ohe Masashi, Kataoka Hiroshi, Mukai Masaya
机构信息
Department of General Medicine, JCHO Hokkaido Hospital, Sapporo, Japan.
Division of Rheumatology and Clinical Immunology, Department of Medicine, Sapporo City General Hospital, Sapporo, Japan.
出版信息
Kaohsiung J Med Sci. 2016 Sep;32(9):484-5. doi: 10.1016/j.kjms.2016.04.007. Epub 2016 May 17.
Abstract
摘要
相似文献
1
A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids.一例使用克拉霉素、他克莫司和糖皮质激素治疗的狼疮性肾炎病例。
Kaohsiung J Med Sci. 2016 Sep;32(9):484-5. doi: 10.1016/j.kjms.2016.04.007. Epub 2016 May 17.
2
Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.患者摘要。狼疮性肾炎诱导治疗的多靶点疗法。
Ann Intern Med. 2015 Jan 6;162(1):I24. doi: 10.7326/P15-9000.
3
Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus.他克莫司成功治疗妊娠期系统性红斑狼疮肾炎活动期
Mod Rheumatol. 2011 Feb;21(1):73-5. doi: 10.1007/s10165-010-0340-4. Epub 2010 Aug 4.
4
Lupus nephritis: Multitarget induction therapy for LN.
Nat Rev Nephrol. 2015 Jan;11(1):3. doi: 10.1038/nrneph.2014.225. Epub 2014 Nov 25.
5
Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.环磷酰胺和他克莫司多靶点疗法治疗狼疮性肾炎的疗效与安全性：日本一项前瞻性、单臂、单中心、开放标签的试点研究
Lupus. 2018 Feb;27(2):273-282. doi: 10.1177/0961203317719148. Epub 2017 Jul 6.
6
Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.免疫抑制药物和糖皮质激素治疗狼疮性肾炎时发生严重感染的风险：一项系统评价和网状Meta分析
BMC Med. 2016 Sep 13;14(1):137. doi: 10.1186/s12916-016-0673-8.
7
Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis.转录组分析揭示狼疮肾炎联合治疗的新协同机制。
Kidney Int. 2018 Feb;93(2):416-429. doi: 10.1016/j.kint.2017.08.031.
8
Celebrating the ACP centennial: from the Annals archive.庆祝美国内科医师学会成立一百周年：来自《内科学年鉴》档案库
Ann Intern Med. 2015 Jan 6;162(1):70. doi: 10.7326/M14-2654.
9
Long-term data on tacrolimus treatment in lupus nephritis.他克莫司治疗狼疮性肾炎的长期数据。
Rheumatology (Oxford). 2014 Dec;53(12):2232-7. doi: 10.1093/rheumatology/keu265. Epub 2014 Jul 4.
10
Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.狼疮肾炎诱导治疗的多靶点治疗：一项随机试验。
Ann Intern Med. 2015 Jan 6;162(1):18-26. doi: 10.7326/M14-1030.
引用本文的文献
1
Successful additional clarithromycin and tacrolimus treatment for hypereosinophilia associated with eosinophilic granulomatosis with polyangiitis.克拉霉素和他克莫司联合治疗嗜酸性肉芽肿性多血管炎相关的嗜酸性粒细胞增多症成功。
Transl Clin Pharmacol. 2018 Jun;26(2):60-63. doi: 10.12793/tcp.2018.26.2.60. Epub 2018 Jun 18.
本文引用的文献
1
Calcineurin inhibitors may be a reasonable alternative to cyclophosphamide in the induction treatment of active lupus nephritis: A systematic review and meta-analysis.在活动性狼疮性肾炎的诱导治疗中，钙调神经磷酸酶抑制剂可能是环磷酰胺的合理替代药物：一项系统评价和荟萃分析。
Exp Ther Med. 2014 Jun;7(6):1663-1670. doi: 10.3892/etm.2014.1669. Epub 2014 Apr 7.
2
Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.他克莫司与环磷酰胺治疗弥漫性增生性或膜性狼疮肾炎：一项非随机前瞻性队列研究。
Lupus. 2012 Aug;21(9):1025-35. doi: 10.1177/0961203312448105. Epub 2012 May 8.
3
Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects.CYP3A5基因多态性对健康日本受试者中他克莫司药代动力学的影响。
Br J Clin Pharmacol. 2008 Jul;66(1):154-5. doi: 10.1111/j.1365-2125.2008.03162.x. Epub 2008 Mar 13.
4
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.
Ther Drug Monit. 2005 Feb;27(1):107-8.
5
Interaction between FK 506 and clarithromycin in a renal transplant patient.
Eur J Clin Pharmacol. 1994;47(2):207-8. doi: 10.1007/BF00194974.
Zotero 插件